Biopharma, Payers Seek National Guidelines For Prescribing Potential COVID-19 Drugs
Executive Summary
Guidelines for US health care providers could help prevent shortages as demand for possible treatments surge, groups say. Stakeholders also argue “Buy America” executive order would hamper drug access.
You may also be interested in...
Supply Chain Truce In COVID-19: Will It Carry Over When Rx Price Debate Resumes?
Manufacturers, insurers, pharmacies and PBMs are united in trying to assure ongoing access to medicines amid the COVID-19 outbreak. Will making common cause in a national emergency mean a more cooperative approach to addressing US drug pricing concerns when normalcy returns?
Off-Label Promoter In Chief: President Trump Pushes COVID-19 Therapy
If the President says over and over again that a drug is approved, does that make it so?
Trump Counts On China To Deliver In The Day Of The Coronavirus
President dismisses fears of drug shortages as White House prepares to deliver US from dependence on China’s pharmaceutical manufacturing complex.